Science news

Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023

Data include three late-breaking abstracts, underscoring Astellas' efforts to potentially redefine expectations for patients across its oncology portfolio TOKYO, Oct. 15, 2023 /PRNewswire/ -- Astellas...

AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn's Disease Meets All Primary and Secondary Endpoints

SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active Crohn's disease who have...

World Health Summit kicks off in Berlin

Experts from around the world meet at the most important forum on global health BERLIN, Oct. 15, 2023 /PRNewswire/ -- The World Health Summit 2023,...

Roswell Park Cancer Innovation SurVaxM Granted FDA Fast Track Designation

Novel cancer immunotherapy is being assessed in nationwide SURVIVE trial in adults with glioblastoma, and in studies for other applications in children and adults....

Promontory Therapeutics Presents Data on the Molecular Effects of PT-112 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

PT-112's mechanism of action promotes immunogenic cancer cell death through ribosomal biogenesis inhibition and organelle stress NEW YORK, Oct. 14, 2023 /PRNewswire/ -- Promontory Therapeutics...

Chinese automotive industry has overtaken to supercars

GUANGZHOU, China, Oct. 14, 2023 /PRNewswire/ -- On the evening of October 9th, China's first supercar production line was officially put into production at...

Raman spectroscopy market to grow by USD 287.28 million from 2022 to 2027 | The rising focus on drug discovery and development to boost...

NEW YORK, Oct. 13, 2023 /PRNewswire/ -- The Raman spectroscopy market by application (pharmaceuticals, life science, material science, semiconductor, and others), type (benchtop and portable), and geography...

Latest articles